These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24792166)

  • 1. Unraveling the regulatory connections between two controllers of breast cancer cell fate.
    Lee J; Tiwari A; Shum V; Mills GB; Mancini MA; Igoshin OA; Balázsi G
    Nucleic Acids Res; 2014 Jun; 42(11):6839-49. PubMed ID: 24792166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
    Kong SL; Li G; Loh SL; Sung WK; Liu ET
    Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).
    Qi J; Huo L; Zhu YT; Zhu YJ
    J Biol Chem; 2014 Nov; 289(45):31373-81. PubMed ID: 25258321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
    Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
    Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway.
    Wilson BJ; Giguère V
    Mol Cancer; 2008 Jun; 7():49. PubMed ID: 18533032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
    McCune K; Bhat-Nakshatri P; Thorat MA; Nephew KP; Badve S; Nakshatri H
    Cancer Res; 2010 Jan; 70(2):685-96. PubMed ID: 20068169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
    Maruani DM; Spiegel TN; Harris EN; Shachter AS; Unger HA; Herrero-González S; Holz MK
    Oncogene; 2012 Dec; 31(49):5073-80. PubMed ID: 22286763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
    Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
    Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
    Erdős E; Bálint BL
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.
    Jiang S; Katayama H; Wang J; Li SA; Hong Y; Radvanyi L; Li JJ; Sen S
    Horm Cancer; 2010 Feb; 1(1):11-20. PubMed ID: 21761347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY; Park YJ; Oh N; Kwack KB; Park KS
    Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
    Licata LA; Hostetter CL; Crismale J; Sheth A; Keen JC
    Breast Cancer Res Treat; 2010 Jul; 122(1):55-63. PubMed ID: 19728080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 in breast cancer.
    Nakshatri H; Badve S
    Expert Rev Mol Med; 2009 Mar; 11():e8. PubMed ID: 19261198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.
    McCune K; Mehta R; Thorat MA; Badve S; Nakshatri H
    Oncol Rep; 2010 Nov; 24(5):1233-9. PubMed ID: 20878115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer.
    Martin EM; Orlando KA; Yokobori K; Wade PA
    Curr Opin Struct Biol; 2021 Dec; 71():65-70. PubMed ID: 34225008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.
    Tian D; Solodin NM; Rajbhandari P; Bjorklund K; Alarid ET; Kreeger PK
    FASEB J; 2015 May; 29(5):2022-31. PubMed ID: 25648997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.